Gene Synthesis Market Analysis 2018-2025 Led by OriGene Technologies, BioCat, Thermo Fisher Scientific, Integrated DNA Technologies, Twist Bioscience, GenScript, Eurofins Scientific, Bioneer Corporation, ATUM and GENEWIZ

The Gene Synthesis Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

The global gene synthesis market estimated to grow at a CAGR of 28.7% during the forecast period from 2018 to 2025. The gene synthesis market was valued at USD 2,866.1 Mn in 2017 and is estimated to reach US$ 20,122.3 Mn by 2025.

Get PDF sample copy: https://bit.ly/2Quqqtw

Leading Players:

1. Thermo Fisher Scientific Inc
2. Integrated DNA Technologies, Inc.
3. Twist Bioscience
4. OriGene Technologies, Inc.
5. BioCat GmbH
6. GenScript
7. Eurofins Scientific
8. Bioneer Corporation
9. ATUM
10. GENEWIZ

The increasing investments & funds, especially for the development of a new enzymatic approach to DNA synthesis is expected to propel the growth for the global gene synthesis market. The technology platform, and other related resources are helping the company to accelerate the development of the gene synthesis. Companies have also increased their research and development funds for the enhancement of the gene synthesis. Additionally, in 2016, Twist Bioscience raised its revenue with US$ 61 million for the scale-up and commercial operation of the silicon chip-based high throughput low-cost gene synthesis platform.

The report highlights the trends prevalent in the global gene synthesis market and the factors driving the market along with those that act as deterrents to its growth.

The global gene synthesis market is segmented on the basis of product & services, application, end user and geography. On the basis of product & services, the gene synthesis market is segmented into consumables, software and services. On the basis of application, the gene synthesis market is segmented into diagnostics, therapeutics, research & developmental activities and others. Based on end user, the gene synthesis market is classified as academic & research institutes, diagnostics laboratories, biotech & pharmaceutical companies and others.

Buy the complete report @ https://bit.ly/2Mi3akc

Gene synthesis contribute in not only to improve the understanding of disease mechanisms, but it also provide novel diagnostic tools. The gene synthesis market is segmented into diagnostics, therapeutics, research & developmental activities and others. The methods based on synthetic biology enables in the development of novel strategies for the treatment of cancer, immune diseases metabolic disorders and infectious diseases and the production of cheap drugs. Moreover, the gene synthesis method is widely accepted for the cancer research studies, from initial studies of oncogenic signaling pathways, to the development of DNA vaccines that used in the prevention of cancer or therapeutic antibodies used for immuno-oncology treatments. Thus, the increasing adoption of the gene synthesis in various application is expected to drive the gene synthesis market over the forecast period.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

This release was published on openPR.